These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7812092)
1. [T-cell-induced prevention of HSV-1 keratitis by immunization with the synthetic peptide of glycoprotein D]. Heiligenhaus A; Berra A; Dutt JE; Zhao TZ; Wells PA; Foster CS Ophthalmologe; 1994 Oct; 91(5):608-16. PubMed ID: 7812092 [TBL] [Abstract][Full Text] [Related]
2. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1. Morrison LA; Knipe DM Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723 [TBL] [Abstract][Full Text] [Related]
3. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. Jayaraman S; Heiligenhaus A; Rodriguez A; Soukiasian S; Dorf ME; Foster CS J Immunol; 1993 Nov; 151(10):5777-89. PubMed ID: 8228262 [TBL] [Abstract][Full Text] [Related]
4. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines. Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288 [TBL] [Abstract][Full Text] [Related]
5. [Glycoprotein D (5-23) specific Th2-T-cell line induces HSV-1 keratitis]. Heiligenhaus A; Jayaraman S; Soukiasian S; Dorf M; Foster CS Ophthalmologe; 1995 Aug; 92(4):484-91. PubMed ID: 7549333 [TBL] [Abstract][Full Text] [Related]
6. Immunisation against HSV-1 keratitis with a synthetic gD peptide. Heiligenhaus A; Wells PA; Foster CS Eye (Lond); 1995; 9 ( Pt 1)():89-95. PubMed ID: 7713256 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge. Frye TD; Chiou HC; Hull BE; Bigley NJ Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314 [TBL] [Abstract][Full Text] [Related]
9. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Ritchie MH; Oakes JE; Lausch RN Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037 [TBL] [Abstract][Full Text] [Related]
10. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis. Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617 [TBL] [Abstract][Full Text] [Related]
11. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. Gangappa S; Babu JS; Thomas J; Daheshia M; Rouse BT J Immunol; 1998 Oct; 161(8):4289-300. PubMed ID: 9780205 [TBL] [Abstract][Full Text] [Related]
12. Analysis of T cell receptor V beta gene expression in B cell deficient mice after experimental herpes simplex virus keratitis. Arrunategui-Correa V; Dutt JE; Foster CS Acta Virol; 1997 Jun; 41(3):145-52. PubMed ID: 9385402 [TBL] [Abstract][Full Text] [Related]
13. Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis. Hu K; He X; Yu F; Yuan X; Hu W; Liu C; Zhao F; Dou J Immunol Invest; 2011; 40(3):265-78. PubMed ID: 21204603 [TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice. Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102 [TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells. Verjans GM; Remeijer L; Mooy CM; Osterhaus AD Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573 [TBL] [Abstract][Full Text] [Related]
16. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis. Bauer D; Wasmuth S; Hennig M; Baehler H; Steuhl KP; Heiligenhaus A Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3188-98. PubMed ID: 19255156 [TBL] [Abstract][Full Text] [Related]
17. An adenovirus-herpes simplex virus glycoprotein B recombinant (Ad-HSV.gB) protects mice against a vaccinia HSV.gB and HSV challenge. Endresz V; Berencsi K; Gönczöl E Acta Microbiol Immunol Hung; 1995; 42(3):247-54. PubMed ID: 8548197 [TBL] [Abstract][Full Text] [Related]
18. Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis. Maertzdorf J; Verjans GM; Remeijer L; van der Kooi A; Osterhaus AD J Infect Dis; 2003 Feb; 187(4):550-8. PubMed ID: 12599071 [TBL] [Abstract][Full Text] [Related]
19. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations. Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241 [TBL] [Abstract][Full Text] [Related]
20. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. Banerjee K; Biswas PS; Rouse BT J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]